Sino Biopharmaceutical (HKG:1177) subsidiary Chia Tai Tianqing Pharmaceutical bought 187,385,000 shares under a share award scheme, according to a Friday filing with the Hong Kong Stock Exchange.
Chia Tai Tianqing bought the shares from May 7 to Sept. 30 for HK$550.6 million.
The remaining share purchase amount is about 500 million yuan, the filing said.
Shares closed 8% higher during Friday's afternoon trading.
Price (HKD): $4.15, Change: $+0.29, Percent Change: +7.51%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments